At a Glance
| Cyclazodone | 3-FMA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 15–25 mg | 20–35 mg |
| Total Duration | 0.3–0.8 hrs | 2.8–6 hrs |
| Routes | oral | oral |
| Effects | 51 documented | 8 documented |
Cyclazodone, a Stimulants, and 3-FMA, a Entactogen, Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Cyclazodone is classified as a Stimulants while 3-FMA is a Entactogen, Stimulants, meaning they approach altered states through different pharmacological mechanisms. They share 5 documented effects in common, with 46 effects unique to Cyclazodone and 3 unique to 3-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Cyclazodone | 3-FMA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (oral) | 15–25 mg | 20–35 mg |
| Total Duration | 0.3–0.8 hrs | 2.8–6 hrs |
| Routes | oral | oral |
| Effects | 51 documented | 8 documented |
| Interaction |
| Caution |
| Level | Cyclazodone | 3-FMA |
|---|---|---|
| Threshold | 5 mg | 5 mg |
| Light | 5–15 mg | 10–20 mg |
| Common | 15–25 mg | 20–35 mg |
| Strong | 25–60 mg | 35–50 mg |
| Heavy | 60 mg | 50 mg |
Cyclazodone
3-FMA
Increased cardiovascular strain and neurotoxicity risk